Satsuma Pharmaceuticals, Inc. Quarterly Return On Equity in % from Q1 2019 to Q1 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Satsuma Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from Q1 2019 to Q1 2023.
  • Satsuma Pharmaceuticals, Inc. Return On Equity for the quarter ending March 31, 2023 was -115 %, a 121% decline year-over-year.
  • Satsuma Pharmaceuticals, Inc. annual Return On Equity for 2022 was -102 %, a 141% decline from 2021.
  • Satsuma Pharmaceuticals, Inc. annual Return On Equity for 2021 was -42.4 %, a 21.4% increase from 2020.
  • Satsuma Pharmaceuticals, Inc. annual Return On Equity for 2020 was -53.9 %, a 5.45% increase from 2019.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2023 -115 -63.1 -121% Jan 1, 2023 Mar 31, 2023
Q4 2022 -102 -59.7 -141% Oct 1, 2022 Dec 31, 2022
Q3 2022 -76 -33.6 -79.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -64.5 -20 -45% Apr 1, 2022 Jun 30, 2022
Q1 2022 -52.1 -4.3 -9% Jan 1, 2022 Mar 31, 2022
Q4 2021 -42.4 +11.5 +21.4% Oct 1, 2021 Dec 31, 2021
Q3 2021 -42.4 +3.9 +8.42% Jul 1, 2021 Sep 30, 2021
Q2 2021 -44.5 -5.45 -14% Apr 1, 2021 Jun 30, 2021
Q1 2021 -47.8 -0.86 -1.83% Jan 1, 2021 Mar 31, 2021
Q4 2020 -53.9 +3.11 +5.45% Oct 1, 2020 Dec 31, 2020
Q3 2020 -46.3 +66 +58.8% Jul 1, 2020 Sep 30, 2020
Q2 2020 -39.1 -129 -143% Apr 1, 2020 Jun 30, 2020
Q1 2020 -46.9 -126 -159% Jan 1, 2020 Mar 31, 2020
Q4 2019 -57 Oct 1, 2019 Dec 31, 2019
Q3 2019 -112 Jul 1, 2019 Sep 30, 2019
Q2 2019 90.3 Apr 1, 2019 Jun 30, 2019
Q1 2019 79.4 Jan 1, 2019 Mar 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.